Viz HCM vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Riverain Technologies

AI Verdict

Viz HCM specializes in the real-time detection of Hypertrophic Cardiomyopathy through ECG analysis and subsequent care coordination. In contrast, ClearRead CT focuses on enhancing the detection of pulmonary nodules and coronary artery calcification within CT scans, primarily aiding radiologists in diagnostic accuracy and efficiency. While both are AI tools within the broader cardiology domain, their distinct input modalities (ECG vs. CT) and specific clinical applications target different stages and aspects of patient care.

Choose Viz HCM if…

Choose Viz HCM if your primary goal is to rapidly identify suspected Hypertrophic Cardiomyopathy (HCM) directly from real-time ECG analysis and immediately activate a coordinated care pathway. This tool is ideal for health systems aiming to significantly reduce diagnosis time and streamline the referral process for this specific, critical cardiac condition.

View Viz HCM →

Choose ClearRead CT if…

Choose ClearRead CT if your focus is on enhancing the accuracy and efficiency of cardiothoracic CT scan interpretation, particularly for pulmonary nodule detection and coronary artery calcification scoring. This solution is best suited for radiology departments seeking to improve diagnostic confidence, reduce reading times, and automate nodule tracking within their existing PACS workflow.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz HCM ClearRead CT
Pricing Unknown Contact for pricing
Deployment Unknown On-premise (stand-alone server, virtual machine) and Cloud
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz HCM

Viz HCM emphasizes mobile-based alerts and real-time coordination for multidisciplinary care teams, suggesting a highly accessible and immediate user experience across a broader range of healthcare professionals. While ClearRead CT streamlines radiologist workflows, Viz HCM's approach enhances overall care team communication and responsiveness.

Clinical Value

Viz HCM

Both tools offer significant clinical value and are FDA-cleared. Viz HCM's focus on real-time ECG analysis for early detection of Hypertrophic Cardiomyopathy and automated care coordination provides a holistic impact on reducing diagnosis and treatment time for a critical condition. ClearRead CT offers quantified improvements in nodule detection accuracy, but Viz HCM's end-to-end impact on the patient journey gives it a slight edge.

Pricing & Value

Viz HCM

Viz HCM provides greater transparency by detailing its subscription-based model and explicitly mentioning CMS reimbursement codes and rates, offering a clear financial value proposition for hospitals. ClearRead CT's 'contact for pricing' approach makes it difficult to assess its economic value without direct vendor engagement.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant (Viz HCM explicitly, ClearRead CT likely due to VA work), and integrate with existing hospital IT systems like EHR and PACS. ClearRead CT offers flexibility with both on-premise and cloud deployment options, while Viz HCM is cloud-based, making them both well-suited for enterprise environments.

Innovation

Viz HCM

Viz HCM demonstrates innovation through its real-time AI-powered ECG analysis for early HCM detection and automated, mobile-enabled care coordination, streamlining the entire patient pathway. ClearRead CT's patented vessel suppression and advanced nodule characterization are also innovative, but Viz HCM's comprehensive impact on disease management provides a broader innovative approach.

Support & Docs

Viz HCM

Viz.ai offers robust support, including 24/7/365 urgent phone support, a comprehensive Knowledge Base, and a 'Trust Center' for detailed compliance documentation. Riverain Technologies provides customer care during business hours and online resources like FAQs and manuals, but Viz.ai's round-the-clock support and explicit transparency in compliance documentation are more comprehensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz HCM ClearRead CT
Name Viz HCM ClearRead CT
Company Viz.ai RIVERAIN TECHNOLOGIES
Tagline AI-powered disease detection and intelligent care coordination for Hypertrophic Cardiomyopathy. AI-Driven Clarity for Faster & More Confident Nodule Detection
Primary Focus Hypertrophic Cardiomyopathy (HCM) detection and cardiac care coordination Pulmonary nodule detection and coronary artery calcification analysis in CT scans
Key Feature 1 AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection Pulmonary Nodule Detection (solid, part-solid, ground glass)
Key Feature 2 Real-time disease detection from electrocardiograms Patented Vessel Suppression (Clear Visual Intelligence)
Key Feature 3 Mobile-based alerts and notifications to multidisciplinary care teams Nodule Characterization and Measurement (volume, diameter, location, type, depth)

Videos

Demos, reviews, and walkthroughs featuring Viz HCM and ClearRead CT.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz HCM is an AI tool focused on detecting suspected Hypertrophic Cardiomyopathy (HCM) using real-time ECG analysis, primarily serving Cardiology, Emergency Medicine, and Hospital Medicine specialties. ClearRead CT, on the other hand, is an AI suite designed for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans, relevant for Cardiology, Pulmonology, and Radiology.
Viz HCM analyzes real-time electrocardiogram (ECG) data to detect signs associated with Hypertrophic Cardiomyopathy. ClearRead CT analyzes computed tomography (CT) scans to enhance the detection of pulmonary nodules and perform coronary artery calcification scoring.
Viz HCM is a cloud-based platform that integrates into hospital IT systems, including EHR and PACS, to streamline cardiac care coordination and clinical workflows. ClearRead CT offers seamless PACS integration and vendor-neutral processing, and can be deployed on-premise or in the cloud.
Yes, Viz HCM has established CMS reimbursement available for CPT codes 0764T and 0765T, with a national payment rate of $128.90 effective January 1, 2025. ClearRead CT's pricing details are available upon contacting the vendor, and specific reimbursement codes are not explicitly mentioned in the provided information.
Viz HCM significantly reduces diagnosis time for HCM, streamlines cardiac care coordination, and provides mobile-based alerts to multidisciplinary care teams. ClearRead CT improves detection accuracy by up to 29% (reducing missed actionable nodules) and reduces reading times by up to 36% for pulmonary nodule detection and CAC scoring, enhancing radiology workflows.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.